The Green Zone: Riders' Jeremy O'Day preparing for 2025
5h ago
O'Day discusses Trevor Harris and changes to be made to get the Riders back to the Grey Cup.
Gormley, Monday, March 1, 2021
8:30 – Canada has approved the AstraZeneca vaccine, and Saskatchewan is expecting 15,000 doses to arrive in the coming weeks, in addition to the Pfizer and Moderna vaccines already being delivered. Dr. Jason Kindrachuk joins Gormley to explain the differences between the vaccines and what you need to know about the newest vaccine to be approved in our country.
LIVE: Dr. Jason Kindrachuk, assistant professor and Canada Research Chair in medical microbiology and infectious diseases, University of Manitoba.
9:00 – The Hour of the Big Stories… Open Session
10:00 – Regina Police Chief Evan Bray joins the show for our regular update on crime and policing issues in the Queen City.
LIVE: Evan Bray, Regina Police Chief.
10:30 – The Saskatchewan Health Authority is launching an online and phone booking system for vaccine appointments, after finding the lists they’ve been using were incomplete. The new system is set to launch later this month, and SHA CEO Scott Livingstone joins Gormley to tell us what the province needs to know about booking vaccinations through the new system.
LIVE: Scott Livingstone, Saskatchewan Health Authority CEO.
11:00 – Did you know that the average parent posts 1,500 photos of their child on social media by the time their kid turns five? Experts are warning that “sharents” might be asking for trouble in the future by giving away not just thousands of photos but heaps of electronic data along with the cute pictures. Are you careful about sharing too many photos of your little ones? Call 1-877-332-8255 and let us know!
12:00 – The Vaccine and Infectious Disease Organization (VIDO) at the U of S saw two major announcements last week. The Saskatchewan Government announced $15M in new funding for pandemic research, and the organization has also partnered with Canada’s Global Nexus at McMaster University to collaborate on vaccine and drug development, clinical trials, and diagnostic tools. VIDO CEO Volker Gerdts joins Gormley to tell us more.
LIVE: Volker Gerdts, CEO of VIDO